Losartan Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Indication (Blood Pressure, Stroke, Heart Disease); Route of Administration (Oral) and Geography

Report Code: TIPRE00017473 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Losartan is an angiotensin II receptor blocker used to treat mild to moderate hypertension as well as stroke in some cases. Losartan is also been used in slowing down long term kidney damage due to type II diabetes. Losartan by blocking angiotensin II receptor help arteries and blood vessels to relax and widen which makes blood flow easy through them. Losartan is available with oral route of administration. The side effects of losartan includes, upper respiratory tract infections, dizziness, stuffy nose, back pain and fatigue.

MARKET DYNAMICS

The key market drivers for Losartan Market Includes, rising prevalence of cardiovascular disorders such as, hypertension, stroke, heart failure. Moreover, increasing geriatric population across the globe is also fueling the market growth. Whereas, wide range of side effects from losartan is expected to restrain market growth during the forecast period.

MARKET SCOPE

The "Losartan Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Losartan market with detailed market segmentation by indication and route of administration. The Losartan Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Losartan Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Losartan Market is segmented on the basis of indication and route of administration. On the basis of indication the market is segmented as, blood pressure, stroke and heart disease. And on the basis of route of administration the market is segmented as by oral route.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Losartan Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Losartan Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Losartan Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Losartan Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Losartan Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Losartan Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Losartan market in the global market. Below mentioned is the list of few companies engaged in the Losartan Market.
The report also includes the profiles of key players in Losartan Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Torrent Pharmaceuticals
  •  Macleods Pharmaceuticals
  •  Merck
  •  Teva Pharmaceuticals
  •  Lupin
  •  Cipla
  •  Sandoz
  •  Sun Pharmaceuticals
  •  Unichem Laboratories
  •  Dr. Reddy's Laboratories

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Losartan Market - By Indication
1.3.2 Losartan Market - By Route of Administration
1.3.3 Losartan Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. LOSARTAN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. LOSARTAN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. LOSARTAN MARKET - GLOBAL MARKET ANALYSIS
6.1. LOSARTAN - GLOBAL MARKET OVERVIEW
6.2. LOSARTAN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. LOSARTAN MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. BLOOD PRESSURE
7.3.1. Overview
7.3.2. Blood Pressure Market Forecast and Analysis
7.4. STROKE
7.4.1. Overview
7.4.2. Stroke Market Forecast and Analysis
7.5. HEART DISEASE
7.5.1. Overview
7.5.2. Heart Disease Market Forecast and Analysis
8. LOSARTAN MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis

9. LOSARTAN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Losartan Market Overview
9.1.2 North America Losartan Market Forecasts and Analysis
9.1.3 North America Losartan Market Forecasts and Analysis - By Indication
9.1.4 North America Losartan Market Forecasts and Analysis - By Route of Administration
9.1.5 North America Losartan Market Forecasts and Analysis - By Countries
9.1.5.1 United States Losartan Market
9.1.5.1.1 United States Losartan Market by Indication
9.1.5.1.2 United States Losartan Market by Route of Administration
9.1.5.2 Canada Losartan Market
9.1.5.2.1 Canada Losartan Market by Indication
9.1.5.2.2 Canada Losartan Market by Route of Administration
9.1.5.3 Mexico Losartan Market
9.1.5.3.1 Mexico Losartan Market by Indication
9.1.5.3.2 Mexico Losartan Market by Route of Administration
9.2. EUROPE
9.2.1 Europe Losartan Market Overview
9.2.2 Europe Losartan Market Forecasts and Analysis
9.2.3 Europe Losartan Market Forecasts and Analysis - By Indication
9.2.4 Europe Losartan Market Forecasts and Analysis - By Route of Administration
9.2.5 Europe Losartan Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Losartan Market
9.2.5.1.1 Germany Losartan Market by Indication
9.2.5.1.2 Germany Losartan Market by Route of Administration
9.2.5.2 France Losartan Market
9.2.5.2.1 France Losartan Market by Indication
9.2.5.2.2 France Losartan Market by Route of Administration
9.2.5.3 Italy Losartan Market
9.2.5.3.1 Italy Losartan Market by Indication
9.2.5.3.2 Italy Losartan Market by Route of Administration
9.2.5.4 Spain Losartan Market
9.2.5.4.1 Spain Losartan Market by Indication
9.2.5.4.2 Spain Losartan Market by Route of Administration
9.2.5.5 United Kingdom Losartan Market
9.2.5.5.1 United Kingdom Losartan Market by Indication
9.2.5.5.2 United Kingdom Losartan Market by Route of Administration
9.2.5.6 Rest of Europe Losartan Market
9.2.5.6.1 Rest of Europe Losartan Market by Indication
9.2.5.6.2 Rest of Europe Losartan Market by Route of Administration
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Losartan Market Overview
9.3.2 Asia-Pacific Losartan Market Forecasts and Analysis
9.3.3 Asia-Pacific Losartan Market Forecasts and Analysis - By Indication
9.3.4 Asia-Pacific Losartan Market Forecasts and Analysis - By Route of Administration
9.3.5 Asia-Pacific Losartan Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Losartan Market
9.3.5.1.1 Australia Losartan Market by Indication
9.3.5.1.2 Australia Losartan Market by Route of Administration
9.3.5.2 China Losartan Market
9.3.5.2.1 China Losartan Market by Indication
9.3.5.2.2 China Losartan Market by Route of Administration
9.3.5.3 India Losartan Market
9.3.5.3.1 India Losartan Market by Indication
9.3.5.3.2 India Losartan Market by Route of Administration
9.3.5.4 Japan Losartan Market
9.3.5.4.1 Japan Losartan Market by Indication
9.3.5.4.2 Japan Losartan Market by Route of Administration
9.3.5.5 South Korea Losartan Market
9.3.5.5.1 South Korea Losartan Market by Indication
9.3.5.5.2 South Korea Losartan Market by Route of Administration
9.3.5.6 Rest of Asia-Pacific Losartan Market
9.3.5.6.1 Rest of Asia-Pacific Losartan Market by Indication
9.3.5.6.2 Rest of Asia-Pacific Losartan Market by Route of Administration
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Losartan Market Overview
9.4.2 Middle East and Africa Losartan Market Forecasts and Analysis
9.4.3 Middle East and Africa Losartan Market Forecasts and Analysis - By Indication
9.4.4 Middle East and Africa Losartan Market Forecasts and Analysis - By Route of Administration
9.4.5 Middle East and Africa Losartan Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Losartan Market
9.4.5.1.1 South Africa Losartan Market by Indication
9.4.5.1.2 South Africa Losartan Market by Route of Administration
9.4.5.2 Saudi Arabia Losartan Market
9.4.5.2.1 Saudi Arabia Losartan Market by Indication
9.4.5.2.2 Saudi Arabia Losartan Market by Route of Administration
9.4.5.3 U.A.E Losartan Market
9.4.5.3.1 U.A.E Losartan Market by Indication
9.4.5.3.2 U.A.E Losartan Market by Route of Administration
9.4.5.4 Rest of Middle East and Africa Losartan Market
9.4.5.4.1 Rest of Middle East and Africa Losartan Market by Indication
9.4.5.4.2 Rest of Middle East and Africa Losartan Market by Route of Administration
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Losartan Market Overview
9.5.2 South and Central America Losartan Market Forecasts and Analysis
9.5.3 South and Central America Losartan Market Forecasts and Analysis - By Indication
9.5.4 South and Central America Losartan Market Forecasts and Analysis - By Route of Administration
9.5.5 South and Central America Losartan Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Losartan Market
9.5.5.1.1 Brazil Losartan Market by Indication
9.5.5.1.2 Brazil Losartan Market by Route of Administration
9.5.5.2 Argentina Losartan Market
9.5.5.2.1 Argentina Losartan Market by Indication
9.5.5.2.2 Argentina Losartan Market by Route of Administration
9.5.5.3 Rest of South and Central America Losartan Market
9.5.5.3.1 Rest of South and Central America Losartan Market by Indication
9.5.5.3.2 Rest of South and Central America Losartan Market by Route of Administration

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. LOSARTAN MARKET, KEY COMPANY PROFILES
11.1. TORRENT PHARMACEUTICALS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. MACLEODS PHARMACEUTICALS
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. MERCK
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. TEVA PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LUPIN
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. CIPLA
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SANDOZ
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SUN PHARMACEUTICALS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. UNICHEM LABORATORIES
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. DR. REDDY'S LABORATORIES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Torrent Pharmaceuticals
2. Macleods Pharmaceuticals
3. Merck
4. Teva Pharmaceuticals
5. Lupin
6. Cipla
7. Sandoz
8. Sun Pharmaceuticals
9. Unichem Laboratories
10. Dr. Reddy's Laboratories
TIPRE00017473
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking